Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors
达唑替纳联合帕博利珠单抗治疗接受低分割放射治疗的特定晚期实体瘤患者的 1b 期研究
期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-25-0566
Cooper, Benjamin T; Iams, Wade T; Page, David B; Yuan, Yuan; Gerber, Naamit K; Luke, Jason J; Gibbs, John P; Gregory, Richard C; Wong, Kwok-Kin; Deng, Jiehui; Perera, Samanthi A; Ding, Kai; Roberts, Emily R; Berger, Allison; Christensen, Camilla L; Tong, Erica Xin; Maldonado López, Angel E; Appleman, Vicky A; Leonard, E Jane; Parent, Alexander; Huang, Yu-Chung; Bay, Camden; Li, Cong; Lineberry, Neil; Raizer, Jeffrey; Olson, Daniel J; Chmura, Steven J